Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-25-000413

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 7, 2025 43.92M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $1.03M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $662.52K
Total Liabilities Q1 2025 · Mar 31, 2025 $132.92K
Total Liabilities Q1 2025 · Dec 31, 2024 $38.55K
Current Assets Q1 2025 · Mar 31, 2025 $1.34M
Current Assets Q1 2025 · Dec 31, 2024 $847.75K
Total Assets Q1 2025 · Mar 31, 2025 $1.39M
Total Assets Q1 2025 · Dec 31, 2024 $873.79K
Rd Expense Q1 2025 · Mar 31, 2025 $37.54K
Rd Expense Q1 2025 · Mar 31, 2024 $805
Shares Diluted Q1 2025 · Mar 31, 2024 41.39M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$48.04K
Stockholders Equity Q1 2025 · Mar 31, 2024 $114.86K
Stockholders Equity Q1 2025 · Dec 31, 2023 −$6.76K
Eps Diluted Q1 2025 · Mar 31, 2024 $0.00
Eps Basic Q1 2025 · Mar 31, 2024 $0.00
Sga Expense Q1 2025 · Mar 31, 2024 $278.29K
Net Income Q1 2025 · Mar 31, 2024 −$53.38K
Operating Income Q1 2025 · Mar 31, 2024 −$53.38K
Gross Profit Q1 2025 · Mar 31, 2024 $234.76K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $42.84K
Revenue Q1 2025 · Mar 31, 2024 $277.6K